That approval requires the manufacturer to demonstrate safety, effectiveness, manufacturing quality, and appropriate labeling
Takeaway: Its a potential helper, but lifestyle changes (visceral fat loss) are still the heavy lifters
This dose reduction can cut ongoing costs by 30 to 50 percent
(2025) The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis, Eating and Weight Disorders Jebeile et al
Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG
55% want to slim down, Gallup (2024) Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial, Nature Medicine (2024) Pharmacy benefits management services, VA.gov Community care network provider quick reference, U.S